A Physiological Model to Evaluate Drug Kinetics in Patients with Hemorrhagic Shock Followed by Fluid Resuscitation

PurposeTo build a physiologically based pharmacokinetic model describing drug kinetics in interstitial fluid in case of hemorrhagic shock, and to propose a simple method to determine the subset of influential parameters that may be estimated with the data at hand.MethodsThe model, which accounts for alterations of regional blood flows and body water distribution, was fitted to amoxicillin and clavulanate kinetic data, assessed in 12 trauma patients with hemorrhagic shock by comparison with 12 healthy volunteers. The predictions were the free concentrations of amoxicillin and clavulanate in 14 organs.ResultsIn all tissues of trauma patients, the rate of distribution was lower, but the steady-state level was higher than those in healthy participants. Blood volume was reduced by 25% and blood flow in organs other than lung, brain, and heart were reduced by 18%. Compared with healthy subjects, the time that free amoxicillin concentration remained above 8 mg/L in the interstitial fluid of trauma patients was higher in blood and muscles, and lower in the tendon compartment.ConclusionsThe results and predictions were consistent with the knowledge in this field. The model may be useful to optimize clinical trial designs and drug dosing regimens.

[1]  S. Shafer.  Shock values. , 2004, Anesthesiology.

[2]  K. Bowker,et al.  Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model , 2004, Antimicrobial Agents and Chemotherapy.

[3]  W. Craig,et al.  In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against Streptococcus pneumoniae: Application to Breakpoint Determinations , 1998, Antimicrobial Agents and Chemotherapy.

[4]  A. Shuaib,et al.  The technique of intracerebral microdialysis. , 2001, Methods.

[5]  Steven Edward Kern,et al.  Influence of Hemorrhagic Shock on Remifentanil: A Pharmacokinetic and Pharmacodynamic Analysis , 2001, Anesthesiology.

[6]  W. Wadsak,et al.  [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans , 2004, Antimicrobial Agents and Chemotherapy.

[7]  Kazuyuki Ikeda,et al.  Relation between Initial Blood Distribution Volume and Propofol Induction Dose Requirement , 2001, Anesthesiology.

[8]  G. Gutierrez,et al.  Clinical review: Hemorrhagic shock , 2004, Critical care.

[9]  Steven Edward Kern,et al.  Influence of Hemorrhagic Shock Followed by Crystalloid Resuscitation on Propofol: A Pharmacokinetic and Pharmacodynamic Analysis , 2004, Anesthesiology.

[10]  Jerome J. Schentag,et al.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response , 1991, Antimicrobial Agents and Chemotherapy.

[11]  H. Wiig,et al.  In vivo determination of steric and electrostatic exclusion of albumin in rat skin and skeletal muscle , 2003, The Journal of physiology.

[12]  A Schumitzky,et al.  Simulation of linear compartment models with application to nuclear medicine kinetic modeling. , 1988, Computer methods and programs in biomedicine.

[13]  M. Tod,et al.  Co-amoxiclav pharmacokinetics during posttraumatic hemorrhagic shock , 2001, Critical care medicine.

[14]  Steven Edward Kern,et al.  The Influence of Hemorrhagic Shock on Propofol: A Pharmacokinetic and Pharmacodynamic Analysis , 2003, Anesthesiology.

[15]  Jerome J. Schentag,et al.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning , 1991, Antimicrobial Agents and Chemotherapy.

[16]  Malcolm Rowland,et al.  Lumping of Whole-Body Physiologically Based Pharmacokinetic Models , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[17]  Lutz Heinemann,et al.  Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects. , 2003, Diabetes technology & therapeutics.

[18]  G. Woodnutt,et al.  Ex Vivo Pharmacodynamics of Amoxicillin-Clavulanate against β-Lactamase-Producing Escherichia coli in a Yucatan Miniature Pig Model That Mimics Human Pharmacokinetics , 2002, Antimicrobial Agents and Chemotherapy.

[19]  R N Pierson,et al.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.

[20]  Steven Edward Kern,et al.  The Influence of Hemorrhagic Shock on Etomidate: A Pharmacokinetic and Pharmacodynamic Analysis , 2003, Anesthesia and analgesia.

[21]  H. Monteil,et al.  Ex vivo 12 h bactericidal activity of oral co-amoxiclav (1.125 g) against beta-lactamase-producing Haemophilus influenzae. , 2001, The Journal of antimicrobial chemotherapy.

[22]  D. Levitt,et al.  The pharmacokinetics of the interstitial space in humans , 2003, BMC clinical pharmacology.

[23]  J. Duranteau,et al.  Heterogeneous regional vascular responses to simulated transient hypovolemia in man , 1994, Intensive Care Medicine.

[24]  P. Leroy,et al.  Comparative assay of amoxicillin by high-performance liquid chromatography and microbiological methods for pharmacokinetic studies in calves , 1992 .

[25]  S. McJames,et al.  Fentanyl pharmacokinetics in hemorrhagic shock: a porcine model. , 1999, Anesthesiology.

[26]  W. Shoemaker.  Circulatory mechanisms of shock and their mediators. , 1987, Critical care medicine.

[27]  C. Reading,et al.  Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography , 1982, Antimicrobial Agents and Chemotherapy.

[28]  S. Harapat,et al.  Computer Simulation of the Effects of Alterations in Blood Flows and Body Composition on Thiopental Pharmacokinetics in Humans , 1997, Anesthesiology.

[29]  T. Kazama,et al.  Influence of Cardiac Output on Plasma Propofol Concentrations during Constant Infusion in Swine , 2002, Anesthesiology.

[30]  M Rowland,et al.  Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. , 1998, The Journal of pharmacology and experimental therapeutics.

[31]  R N Upton,et al.  Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. , 1999, Anesthesia and analgesia.

[32]  J. Marty,et al.  Physiological Modeling for Indirect Evaluation of Drug Tissular Pharmacokinetics under Non-Steady-State Conditions: An Example of Antimicrobial Prophylaxis During Liver Surgery , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[33]  Russell D. Wada,et al.  Application of Physiologic Models to Predict the Influence of Changes in Body Composition and Blood Flows on the Pharmacokinetics of Fentanyl and Alfentanil in Patients , 1998, Anesthesiology.

[34]  Richard N Upton,et al.  A Physiologically Based, Recirculatory Model of the Kinetics and Dynamics of Propofol in Man , 2005, Anesthesiology.